Production (Stage)
InterCure Ltd.
INCR
$1.50
$0.032.04%
NASDAQ
| 12/31/2024 | 09/30/2024 | 12/31/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 15.28M | 15.26M | 19.28M | 28.08M | 30.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.28M | 15.26M | 19.28M | 28.08M | 30.06M |
| Cost of Revenue | 15.23M | 15.21M | 14.52M | 19.05M | 18.92M |
| Gross Profit | 52.80K | 52.70K | 4.77M | 9.03M | 11.13M |
| SG&A Expenses | 8.60M | 8.59M | 6.10M | 7.08M | 7.41M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 4.69M | 4.69M | 183.90K | 328.40K | 1.99M |
| Total Operating Expenses | 28.54M | 28.50M | 20.82M | 26.48M | 28.37M |
| Operating Income | -13.26M | -13.25M | -1.53M | 1.60M | 1.68M |
| Income Before Tax | -11.99M | -11.98M | -8.33M | 110.50K | 502.20K |
| Income Tax Expenses | -2.16M | -2.16M | 510.30K | -910.60K | 476.10K |
| Earnings from Continuing Operations | -9.83M | -9.82M | -8.84M | 1.02M | 26.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 480.80K | 480.10K | 38.60K | 317.40K | 34.50K |
| Net Income | -9.35M | -9.34M | -8.80M | 1.34M | 60.60K |
| EBIT | -13.26M | -13.25M | -1.53M | 1.60M | 1.68M |
| EBITDA | -12.61M | -12.69M | -995.10K | 2.47M | 2.58M |
| EPS Basic | -0.21 | -0.21 | -0.20 | 0.03 | 0.00 |
| Normalized Basic EPS | -0.20 | -0.20 | -0.04 | -- | 0.01 |
| EPS Diluted | -0.21 | -0.21 | -0.20 | 0.03 | 0.00 |
| Normalized Diluted EPS | -0.20 | -0.20 | -0.04 | -- | 0.01 |
| Average Basic Shares Outstanding | 43.97M | 43.97M | 44.81M | 49.87M | 42.80M |
| Average Diluted Shares Outstanding | 43.97M | 43.97M | 44.81M | 49.87M | 42.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |